These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 22858262
1. A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression. Goldberg JF. J Affect Disord; 2013 Jan 10; 144(1-2):176-8. PubMed ID: 22858262 [Abstract] [Full Text] [Related]
2. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA. J Clin Psychiatry; 1998 May 10; 59(5):246-53. PubMed ID: 9632036 [Abstract] [Full Text] [Related]
3. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone. Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP. J Clin Psychiatry; 1999 Apr 10; 60(4):226-31. PubMed ID: 10221282 [Abstract] [Full Text] [Related]
4. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study. Saiz-Ruiz J, Ibañez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F. CNS Drugs; 2002 Apr 10; 16(9):635-43. PubMed ID: 12153334 [Abstract] [Full Text] [Related]
5. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. Amsterdam JD, Wang CH, Shwarz M, Shults J. J Affect Disord; 2009 Jan 10; 112(1-3):219-30. PubMed ID: 18486235 [Abstract] [Full Text] [Related]
6. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Goldberg JF, Burdick KE, Endick CJ. Am J Psychiatry; 2004 Mar 10; 161(3):564-6. PubMed ID: 14992985 [Abstract] [Full Text] [Related]
8. Using antipsychotic agents in older patients. Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. J Clin Psychiatry; 2004 Mar 10; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733 [Abstract] [Full Text] [Related]
9. An open-label trial of nefazodone in high comorbidity panic disorder. DeMartinis NA, Schweizer E, Rickels K. J Clin Psychiatry; 1996 Jun 10; 57(6):245-8. PubMed ID: 8666561 [Abstract] [Full Text] [Related]
10. Nefazodone for chronic daily headache prophylaxis: an open-label study. Saper JR, Lake AE, Tepper SJ. Headache; 2001 May 10; 41(5):465-74. PubMed ID: 11380644 [Abstract] [Full Text] [Related]
11. An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding. Mischoulon D, Dougherty DD, Bottonari KA, Gresham RL, Sonawalla SB, Fischman AJ, Fava M. Psychiatry Res; 2002 Dec 30; 116(3):151-61. PubMed ID: 12477599 [Abstract] [Full Text] [Related]
12. An open-label study of amisulpride in the treatment of mania. Vieta E, Ros S, Goikolea JM, Benabarre A, Popova E, Comes M, Capapey J, Sánchez-Moreno J. J Clin Psychiatry; 2005 May 30; 66(5):575-8. PubMed ID: 15889942 [Abstract] [Full Text] [Related]
13. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. J Clin Psychiatry; 2009 Oct 30; 70(10):1424-31. PubMed ID: 19906346 [Abstract] [Full Text] [Related]
20. Treatment of somatization disorder with nefazodone: a prospective, open-label study. Menza M, Lauritano M, Allen L, Warman M, Ostella F, Hamer RM, Escobar J. Ann Clin Psychiatry; 2001 Sep 30; 13(3):153-8. PubMed ID: 11791953 [Abstract] [Full Text] [Related] Page: [Next] [New Search]